We cannot determine whether IL-6 is an active mediator in preeclampsia or a marker of immune activation, and it seems necessary to perform further studies, including longitudinal studies before the onset of preeclampsia, to elucidate the role of this cytokine in the pathogenesis of preeclampsia. Here, IL6 is linked to preeclampsia.